Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy.

Abstract:

:We studied the effect of beta 2-GPI on binding of antibodies in sera from patients with leprosy and patients with the antiphospholipid syndrome (APS) to CL in enzyme-linked immunosorbent assays (ELISAs). Increased levels of IgG aCL were detected in 59 of 61 leprosy patients' sera by the standard aCL-ELISA in the presence of bovine beta 2-GPI and in 60 of the 61 leprosy patients' sera by the modified aCL-ELISA without beta 2-GPI. When tested by both aCL-ELISAs on the same plate, 10/31 leprosy sera and 9/10 APS sera bound better in the standard aCL-ELISA, 16/31 leprosy sera bound better in the modified aCL-ELISA and in five leprosy and one APS sera the difference was not significant. A dose-dependent enhancing effect of beta 2-GPI on the leprosy and APS sera binding to CL was confirmed using purified human beta 2-GPI. Enhanced binding was seen if beta 2-GPI was added either before or together with the test serum. In 11/61 leprosy sera increased levels of IgG antibodies against beta 2-GPI were found by ELISA. Leprosy anti-beta 2-GPI antibodies appear to be a separate antibody population recognizing only beta 2-GPI adsorbed on the ELISA plate. These results demonstrate heterogeneity of leprosy aCL with respect to their beta 2-GPI requirement for binding to CL.

journal_name

Lupus

journal_title

Lupus

authors

Hojnik M,Gilburd B,Ziporen L,Blank M,Tomer Y,Scheinberg MA,Tincani A,Rozman B,Shoenfeld Y

doi

10.1177/096120339400300615

subject

Has Abstract

pub_date

1994-12-01 00:00:00

pages

515-21

issue

6

eissn

0961-2033

issn

1477-0962

journal_volume

3

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Familial SLE: sustained drug-free remission in a mother successfully treated for anal cancer, but development of SLE in a 16-year old daughter.

    abstract::The immunopathogenesis of systemic lupus erythematosus has been thoroughly investigated recently, and genome-wide association studies have identified genes statistically associated with lupus. However, the progression to overt disease is dependent on the activation of environmental factors ('triggers'), among which oe...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311433138

    authors: Catania G,Rossi E,Marmont A

    更新日期:2012-05-01 00:00:00

  • Early-stage predictors for treatment responses in patients with active lupus nephritis.

    abstract:OBJECTIVE:We analyzed data of lupus nephritis (LN) patients to find parameters that can predict remission. METHODS:Sixty-four LN patients who were diagnosed with class III, IV, V or V + III/IV by renal biopsy and were followed up for more than six months in our center were enrolled retrospectively. Receiver operating ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319826703

    authors: Liu G,Wang H,Le J,Lan L,Xu Y,Yang Y,Chen J,Han F

    更新日期:2019-03-01 00:00:00

  • SLEDAI-2K for a 30-day window.

    abstract::The aim of our study was to determine whether the SLEDAI-2K calculated using a timeframe of 30 days prior to a visit for clinical and laboratory variables was equivalent to the prescribed 10-day period. One hundred forty nine consecutive lupus patients seen over 9 weeks at the University of Toronto Lupus Clinic enroll...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309346505

    authors: Touma Z,Urowitz MB,Gladman DD

    更新日期:2010-01-01 00:00:00

  • High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.

    abstract::Abnormalities of the lipid profile partly explain the atherogenic tendency of systemic lupus erythematosus but the picture is unclear in thrombotic primary antiphospholipid syndrome (PAPS). Herein we compare the lipid profile, high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol (CHO), apol...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309357765

    authors: Ames PR,Matsuura E,Batuca JR,Ciampa A,Lopez LL,Ferrara F,Iannaccone L,Alves JD

    更新日期:2010-05-01 00:00:00

  • Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study.

    abstract:OBJECTIVE:The objective of this paper is to assess whether pulmonary hypertension (PH) may be detected at one point in time or longitudinally predicted by serum uric acid (sUA) levels in systemic lupus erythematosus (SLE). METHODS:We conducted a post-hoc analysis of a long-term followed cohort of Mexican SLE patients....

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315600539

    authors: Castillo-Martínez D,Marroquín-Fabián E,Lozada-Navarro AC,Mora-Ramírez M,Juárez M,Sánchez-Muñoz F,Vargas-Barrón J,Sandoval J,Amezcua-Guerra LM

    更新日期:2016-01-01 00:00:00

  • Human Fc gamma receptor IIA (FcgammaRIIA) genotyping and association with systemic lupus erythematosus (SLE) in Chinese and Malays in Malaysia.

    abstract::SLE is an autoimmune and polygenic disorder characterized by an accumulation and deposition of immune complexes. Several studies have indicated differential impact of FcgammaR polymorphism genotypes in different ethnic groups studied. The Fc receptor for IgG class IIA gene (FcgammaRIIA) occurs in two allelic forms. Th...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847876

    authors: Yap SN,Phipps ME,Manivasagar M,Tan SY,Bosco JJ

    更新日期:1999-01-01 00:00:00

  • Bilateral choroidopathy in systemic lupus erythematosus.

    abstract::We report a case of bilateral choroidopathy in a 35-year-old woman with systemic lupus erythematosus (SLE) diagnosed 3 years previously, and treated with hydroxychloroquine and steroids that ceased 6 months before ocular signs. She complained about rapid bilateral blurred vision with a severe loss of visual acuity. Fl...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203311398510

    authors: Edouard S,Douat J,Sailler L,Arlet P,Astudillo L

    更新日期:2011-10-01 00:00:00

  • Cytomegalovirus infection in Systemic Lupus Erythematosus: report of four cases challenging the management of the disease, and literature review.

    abstract::Cytomegalovirus (CMV) is particularly dangerous in systemic lupus erythematosus (SLE), being a problem both for the differential diagnosis with disease flare and for the management of SLE flare with immunosuppressive drugs. We report on four cases of SLE with concomitant CMV infection, having some common clinical and ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319825570

    authors: Sebastiani GD,Iuliano A,Canofari C,Bracci M

    更新日期:2019-03-01 00:00:00

  • Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study.

    abstract::The relationship between disease activity, cumulative damage and self-reported quality of life was examined in 96 patients with Systematic Lupus Erythematosus (SLE). Disease activity was measured by the SLE Disease Activity Index (SLEDAI) and cumulative damage by the Systematic Lupus International Cooperating Clinics/...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600305

    authors: Hanly JG

    更新日期:1997-01-01 00:00:00

  • Annexin A2: biology and relevance to the antiphospholipid syndrome.

    abstract::Antiphospholipid antibodies (aPL), the majority of which are directed against beta(2)-glycoprotein I (beta(2)GPI), are associated with an increased incidence of venous and arterial thrombosis. The pathogenesis of antiphospholipid/anti-beta(2)GPI-associated thrombosis has not been defined, and is likely multifactorial....

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308095329

    authors: Cockrell E,Espinola RG,McCrae KR

    更新日期:2008-10-01 00:00:00

  • Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse.

    abstract::Tissue damage associated with a severe injury can result in profound inflammatory responses that may trigger autoimmune development in lupus-prone individuals. In this study, we investigated the role of a large full-thickness cutaneous burn injury on the early onset of autoimmune disease in lupus-prone MRL/++ mice. MR...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308097479

    authors: Anam K,Amare M,Naik S,Szabo KA,Davis TA

    更新日期:2009-04-01 00:00:00

  • The lupus patient with positive rheumatoid factor.

    abstract::Background Patients with systemic lupus erythematosus (SLE) may form clusters with clinical manifestations and autoantibodies. Objective The objective of this report is to study whether SLE patients with positive rheumatoid factor (RF) have a special clinical and/or serological profile. Methods A retrospective study o...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318759607

    authors: Fedrigo A,Dos Santos TAFG,Nisihara R,Skare T

    更新日期:2018-07-01 00:00:00

  • High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is an immune-mediated disease that is responsive to suppression or modulation of the immune system. Patients with SLE who experience persistent multiorgan dysfunction, despite standard doses of intravenous cyclophosphamide (Cy), represent a subset of patients at high risk of early de...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu491oa

    authors: Lisukov IA,Sizikova SA,Kulagin AD,Kruchkova IV,Gilevich AV,Konenkova LP,Zonova EV,Chernykh ER,Leplina OY,Sentyakova TN,Demin AA,Kozlov VA

    更新日期:2004-01-01 00:00:00

  • Allogeneic adipose-derived stem cells suppress mTORC1 pathway in a murine model of systemic lupus erythematosus.

    abstract:OBJECTIVE:The aim of our study was to investigate the efficacy of adipose-derived stem cells (ADSC) transplantation in systemic lupus erythematosus (SLE) and to determine the mechanism of ADSC transplantation. METHODS:B6.MRL/lpr mice were administered ADSC intravenously every week from age 28 to 31 weeks, while the lu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318819131

    authors: Wei S,Xie S,Yang Z,Peng X,Gong L,Zhao K,Zeng K,Lai K

    更新日期:2019-02-01 00:00:00

  • Predictors of kidney disease in a cohort of pediatric patients with lupus.

    abstract:INTRODUCTION:Children with systemic lupus erythematosus (SLE) have an increased prevalence of kidney disease compared to their adult counterparts. Our goal was to identify potential clinical and laboratory predictors of renal disease. METHODS:We performed a cohort study of incident and prevalent patients with SLE aged...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315570162

    authors: Sule SD,Moodalbail DG,Burnham J,Fivush B,Furth SL

    更新日期:2015-07-01 00:00:00

  • Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.

    abstract:OBJECTIVES:To estimate the prevalence of pulmonary arterial hypertension (PAH) and risk factors for PAH in patients registered in the Chinese SLE Treatment and Research group (CSTAR) database, the first online registry of Chinese patients with systemic lupus erythematosus (SLE). METHODS:A prospective cross-sectional s...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314527366

    authors: Li M,Wang Q,Zhao J,Li Z,Ye Z,Li C,Li X,Zhu P,Wang Z,Zheng Y,Li X,Zhang M,Tian Z,Liu Y,He J,Zhang F,Zhao Y,Zeng X,CSTAR co-authors.

    更新日期:2014-09-01 00:00:00

  • Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?

    abstract:OBJECTIVE:YB current affiliation: Department of Pediatrics, Hadassah-Hebrew University Medical Center, Mount Scopus, Israel YB and MJS contributed equally to the study and should be regarded as joint first authors on this manuscript. Antiphospholipid syndrome (APS) may present with thrombosis and persistently elevated ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314531842

    authors: Berkun Y,Simchen MJ,Strauss T,Menashcu S,Padeh S,Kenet G

    更新日期:2014-09-01 00:00:00

  • Qualitative validation of the FACIT-fatigue scale in systemic lupus erythematosus.

    abstract:OBJECTIVE:Fatigue in systemic lupus erythematosus (SLE) is burdensome and must be assessed using validated scales. Although the psychometric properties of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) scale in SLE have been evaluated previously, its content validity in this disease remain...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313476360

    authors: Kosinski M,Gajria K,Fernandes AW,Cella D

    更新日期:2013-04-01 00:00:00

  • 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome.

    abstract::Obstetric antiphospholipid syndrome (APS) remains a clinical challenge for practitioners, with several controversial points that have not been answered so far. This Obstetric APS Task Force met on the 16th International Congress on Antiphospholipid Antibodies in Manchester, England, to discuss about treatment, diagnos...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320954520

    authors: de Jesús GR,Benson AE,Chighizola CB,Sciascia S,Branch DW

    更新日期:2020-10-01 00:00:00

  • The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity.

    abstract::This study investigates specificity, sensitivity and concomitant presence of antibodies against histone H1 (H1), nucleosomes (NUC), chromatin (CHR) and dsDNA in patients with systemic lupus erythematosus (SLE), analyses their association with SLE disease activity and characterizes the immunodominant epitope reactivity...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203302lu247oa

    authors: Schett G,Smole J,Zimmermann C,Hiesberger H,Hoefler E,Fournel S,Muller S,Rubin RL,Steiner G

    更新日期:2002-01-01 00:00:00

  • Low C4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus.

    abstract:OBJECTIVE:This study aimed to explore the risk factors for 'severe' neuropsychiatric (NP) flare in patients with systemic lupus erythematosus (SLE). METHODS:This retrospective study comprised newly diagnosed 184 adult SLE patients who visited Hokkaido University Hospital between 2006 and 2017. In this study, severe NP...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320938453

    authors: Aso K,Kono M,Kono M,Watanabe T,Shimizu Y,Ogata Y,Fujieda Y,Kato M,Oku K,Amengual O,Yasuda S,Atsumi T

    更新日期:2020-09-01 00:00:00

  • Interstitial inflammation and long-term renal outcomes in lupus nephritis.

    abstract:INTRODUCTION:The International Society of Nephrology/Renal Pathology Society (ISN/RPS) pathological classification criteria of lupus nephritis are limited to glomerular injury. Although the tubulointerstitium is commonly involved, the importance of such involvement is not well defined. The major objective of this study...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313507986

    authors: Alsuwaida AO

    更新日期:2013-12-01 00:00:00

  • Management of antiphospholipid antibody positivity and elective orthopedic procedures.

    abstract::Current management of primary or secondary antiphospholipid antibody (aPL) syndromes with known embolic phenomena requiring anticoagulation is empiric in the setting of elective orthopedic procedures. Short-term withdrawal of warfarin with continuance of aspirin and glucocorticoid therapy was undertaken for sequential...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100311

    authors: Schnitz WM,Lister KA,McCarty GA

    更新日期:1992-05-01 00:00:00

  • The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center.

    abstract::We retrospectively evaluated the clinical outcome of 45 female and 11 male patients with biopsy-proven lupus nephritis, followed at our hospital between February 1974 and February 1990. In the majority signs of nephritis were present at the time systemic lupus erythematosus was diagnosed (range: -42-156 months) and th...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100207

    authors: Derksen RH,Hené RJ,Kater L

    更新日期:1992-02-01 00:00:00

  • Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.

    abstract::Although challenging, developing evidence-based approaches to an early and accurate diagnosis of systemic lupus erythematosus is a key approach to preventing disease and lupus-associated morbidity and mortality. Advances in our understanding of preclinical and incomplete lupus erythematosus have enabled the identifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203316640367

    authors: Choi MY,Barber MR,Barber CE,Clarke AE,Fritzler MJ

    更新日期:2016-07-01 00:00:00

  • Twenty-year follow-up: an unusual case of nephropathy of antiphospholipid syndrome.

    abstract::Nephropathy of antiphospholipid antibody syndrome (NAPS) is an increasingly well-recognized aspect of antiphospholipid syndrome. The most characteristic histopathology is that of thrombotic microangiopathy, and thrombosis occurring in the renal vasculature is thought to be the initiating event. Other less common patho...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308098629

    authors: Lin YQ,Lakshminarayanan S,Yamase H,Palmisano J,Parke A

    更新日期:2009-05-01 00:00:00

  • Renal transplantation for lupus nephritis: non-adherence and graft survival.

    abstract:OBJECTIVES:Poor adherence to immunosuppressive treatment is common in patients with systemic lupus erythematosus and may identify those with lupus nephritis (LN) who have a poorer prognosis. Non-adherence has also been reported to be a potential adverse outcome predictor in renal transplantation (rTp). We investigated ...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203319842641

    authors: Ntatsaki E,Vassiliou VS,Velo-Garcia A,Salama AD,Isenberg DA

    更新日期:2019-04-01 00:00:00

  • Massive ovarian haemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: a report of three cases.

    abstract::We report three cases of severe haemorrhagic rupture of luteal ovarian cyst requiring surgical haemostasis in young women treated with long-term oral anticoagulation for antiphospholipid syndrome (APS) who used no contraception. At the time of bleeding, the international normalized ratios were 3.78, 4.24, and 7.11. An...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339900800614

    authors: Crétel E,Cacoub P,Huong DL,Gompel A,Amoura Z,Piette JC

    更新日期:1999-01-01 00:00:00

  • Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus.

    abstract::Peripheral T cell apoptosis is upregulated in active SLE, in parallel with high expression of both membrane-bound and soluble (s) Fas. Previous studies postulated that sFas down-regulates apoptosis in vitro through its blockade of the Fas-L of cytotoxic cells. We have investigated the extent of apoptosis and sFas leve...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu250oa

    authors: Silvestris F,Grinello D,Tucci M,Cafforio P,Dammacco F

    更新日期:2003-01-01 00:00:00

  • Striking alteration of some populations of T/B cells in systemic lupus erythematosus: relationship to expression of CD62L or some chemokine receptors.

    abstract::Recent studies have revealed new populations of T/B cells, including central/effector memory, follicular T cells and CXCR3+ or CXCR4+ B cells. In the present study, changes in these populations of CD4+ T cells were examined on the basis of the expression of CD62L, CCR7 and CXCR5 in patients with systemic lupus erythem...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307085246

    authors: Watanabe T,Suzuki J,Mitsuo A,Nakano S,Tamayama Y,Katagiri A,Amano H,Morimoto S,Tokano Y,Takasaki Y

    更新日期:2008-01-01 00:00:00